vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and VinFast Auto Ltd. (VFS). Click either name above to swap in a different company.
VinFast Auto Ltd. is the larger business by last-quarter revenue ($718.6M vs $493.8M, roughly 1.5× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -2.8%, a 9.6% gap on every dollar of revenue.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
VinFast Auto Ltd. is a Vietnamese multinational automotive company founded by Vingroup, one of the largest private conglomerates in Vietnam that was founded by Phạm Nhật Vượng.
MD vs VFS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $718.6M |
| Net Profit | $33.7M | $-20.0M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | -96.1% |
| Net Margin | 6.8% | -2.8% |
| Revenue YoY | -1.7% | — |
| Net Profit YoY | 10.5% | — |
| EPS (diluted) | $0.40 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | — | ||
| Q3 25 | $492.9M | $718.6M | ||
| Q2 25 | $468.8M | $663.0M | ||
| Q1 25 | $458.4M | $656.5M | ||
| Q4 24 | $502.4M | — | ||
| Q3 24 | $511.2M | $511.6M | ||
| Q2 24 | $504.3M | — | ||
| Q1 24 | $495.1M | $302.6M |
| Q4 25 | $33.7M | — | ||
| Q3 25 | $71.7M | $-20.0M | ||
| Q2 25 | $39.3M | $-51.8M | ||
| Q1 25 | $20.7M | $-26.1M | ||
| Q4 24 | $30.5M | — | ||
| Q3 24 | $19.4M | $-10.4M | ||
| Q2 24 | $-153.0M | — | ||
| Q1 24 | $4.0M | $-618.3M |
| Q4 25 | 9.9% | — | ||
| Q3 25 | 13.8% | -96.1% | ||
| Q2 25 | 12.8% | -79.0% | ||
| Q1 25 | 7.0% | -74.0% | ||
| Q4 24 | 7.8% | — | ||
| Q3 24 | 6.6% | -65.9% | ||
| Q2 24 | -31.3% | — | ||
| Q1 24 | 3.2% | -139.4% |
| Q4 25 | 6.8% | — | ||
| Q3 25 | 14.5% | -2.8% | ||
| Q2 25 | 8.4% | -7.8% | ||
| Q1 25 | 4.5% | -4.0% | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 3.8% | -2.0% | ||
| Q2 24 | -30.3% | — | ||
| Q1 24 | 0.8% | -204.3% |
| Q4 25 | $0.40 | — | ||
| Q3 25 | $0.84 | — | ||
| Q2 25 | $0.46 | — | ||
| Q1 25 | $0.24 | — | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.23 | — | ||
| Q2 24 | $-1.84 | — | ||
| Q1 24 | $0.05 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $8.8M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | — |
| Total Assets | $2.2B | $183.2M |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | — | ||
| Q3 25 | $340.1M | $8.8M | ||
| Q2 25 | $224.7M | $650.0M | ||
| Q1 25 | $99.0M | $2.4M | ||
| Q4 24 | $229.9M | — | ||
| Q3 24 | $103.8M | $1.9M | ||
| Q2 24 | $19.4M | — | ||
| Q1 24 | $8.0M | $3.0M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | — | ||
| Q3 25 | $890.7M | — | ||
| Q2 25 | $833.8M | $-7.2B | ||
| Q1 25 | $789.2M | — | ||
| Q4 24 | $764.9M | — | ||
| Q3 24 | $732.5M | — | ||
| Q2 24 | $706.5M | — | ||
| Q1 24 | $856.2M | — |
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $183.2M | ||
| Q2 25 | $2.1B | $7.2B | ||
| Q1 25 | $2.0B | $158.2M | ||
| Q4 24 | $2.2B | — | ||
| Q3 24 | $2.1B | $151.8M | ||
| Q2 24 | $2.0B | — | ||
| Q1 24 | $2.2B | $145.6M |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | — | ||
| Q3 25 | $137.3M | — | ||
| Q2 25 | $137.2M | — | ||
| Q1 25 | $-117.5M | — | ||
| Q4 24 | $133.0M | — | ||
| Q3 24 | $91.8M | — | ||
| Q2 24 | $107.0M | — | ||
| Q1 24 | $-125.2M | — |
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -31.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
VFS
| Sales of vehicles | $662.9M | 92% |
| Sales of spare parts and components | $41.3M | 6% |
| Revenue from leasing activities | $12.3M | 2% |
| Finance income | $2.4M | 0% |
| Rendering of services | $1.2M | 0% |
